Related Experiment Video
Updated: Feb 12, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Antibody-mediated rejection induced cardiogenic shock: Too late for conventional therapy
Guillaume Coutance1, Lucas Van Aelst1,2, Guillaume Hékimian3
1Department of Cardiac and Thoracic Surgery, Cardiology Institute, Pitié Salpêtrière Hospital, University of Paris VI, Paris, France.
Insights
Prognosis for heart transplant recipients experiencing antibody-mediated rejection (AMR) with cardiogenic shock (CS) is poor. Aggressive treatment showed high mortality, with most cases linked to de novo donor-specific antibodies (DSA).
Area of Science:
- Cardiology
- Transplantation Immunology
Background:
- Data on the prognosis of heart allograft antibody-mediated rejection (AMR) complicated by cardiogenic shock (CS) are limited.
- Antibody-mediated rejection (AMR) is a significant concern following heart transplantation.
Purpose of the Study:
- To analyze the characteristics, treatment, and outcomes of patients with biopsy-proven AMR and CS.
- To investigate the prognosis and recurrence of AMR in heart transplant recipients with CS.
Main Methods:
- Retrospective, single-center observational study.
- Inclusion criteria: biopsy-proven AMR and CS.
- Follow-up for graft function, AMR recurrence, and cardiac allograft vasculopathy (CAV) in survivors.
Main Results:
- Seventeen patients (70% male, median age 56 years) were included; AMR occurred at a median of 21 months post-transplant.
- Most cases involved de novo class II donor-specific antibodies (DSA); only 2 had prior AMR history.
- In-hospital and 1-year mortality rates were high (76% and 82%, respectively), despite aggressive immunosuppression.
Conclusions:
- Cardiogenic shock due to AMR, particularly with de novo class II DSA, carries a poor prognosis.
- Aggressive conventional immunosuppressive therapies demonstrated limited efficacy in improving survival for these patients.
Background:
Data are scarce on the prognosis of heart allograft antibody-mediated rejection (AMR) with cardiogenic shock (CS).
Methods:
We performed a retrospective, single center, observational study. We included patients with biopsy-proven AMR and CS. We aimed to analyze the characteristics, treatment, and prognosis of patients treated for CS due to AMR. Patients alive after AMR were followed to analyze recurrences of AMR, graft function, and cardiac allograft vasculopathy (CAV).
Results:
Seventeen patients met the inclusion criteria. Patients were mostly males (70%). Median age at diagnosis was 56 years, and median time between heart transplantation and AMR was 21 months. AMR was mostly due to high-level de novo class II DSA. Only 2 patients had past history of biopsy-proven AMR. Despite aggressive immunosuppressive therapies, in-hospital and 1-year mortality were as high as 76% and 82%, respectively. Four patients were discharged from hospital. Two of them were diagnosed with recurrent subclinical AMR: one died suddenly and the other presented rapidly progressive CAV.
Conclusion:
CS due to AMR occurred mostly in patients without history of AMR who developed de novo class II DSA. Despite aggressive conventional immunosuppressive therapies, prognosis after CS due to AMR was poor.
More Related Videos
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Sign Convention
The normal force acts perpendicular to the beam's cross-section and can...
Shock Waves
When the source's speed approaches the speed of sound, constructive interference between successive wavefronts emitted by the source occurs immediately behind it. Initially, scientists believed that this constructive interference would result in such high...
Enolate Mechanism Conventions
Hypothesis: Accept or Fail to Reject?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
Quantifying and Rejecting Outliers: The Grubbs Test

